Podcasts about clinical applications

As artificial intelligence (AI) tools become increasingly mainstream, they can potentially transform neurology clinical practice by improving patient care and reducing clinician workload. Critically evaluating these AI tools for clinical practice is important for successful implementation. In this episode, Katie Grouse, MD, FAAN speaks with Peter Hadar, MD, MS, coauthor of the article “Clinical Applications of Artificial Intelligence in Neurology Practice” in the Continuum® April 2025 Neuro-ophthalmology issue. Dr. Grouse is a Continuum® Audio interviewer and a clinical assistant professor at the University of California San Francisco in San Francisco, California. Dr. Hadar is an instructor of neurology at Harvard Medical School and an attending physician at the Massachusetts General Hospital in Boston, Massachusetts. Additional Resources Read the article: Clinical Applications of Artificial Intelligence in Neurology Practice Subscribe to Continuum®: shop.lww.com/Continuum Continuum® Aloud (verbatim audio-book style recordings of articles available only to Continuum® subscribers): continpub.com/Aloud More about the American Academy of Neurology: aan.com Social Media facebook.com/continuumcme @ContinuumAAN Guest: @PeterNHadar Full episode transcript available here Dr Jones: This is Dr Lyell Jones, Editor-in-Chief of Continuum. Thank you for listening to Continuum Audio. Be sure to visit the links in the episode notes for information about subscribing to the journal, listening to verbatim recordings of the articles, and exclusive access to interviews not featured on the podcast. Dr Grouse: This is Dr Katie Grouse. Today I'm interviewing Dr Peter Hadar about his article on clinical applications of artificial intelligence in neurology practice, which he wrote with Dr Lydia Moura. This article appears in the April 2025 Continuum issue on neuro-ophthalmology. Welcome to the podcast, and please introduce yourself to our audience. Dr Hadar: Hi, thanks for having me on, Katie. My name is Dr Peter Hadar. I'm currently an instructor over at Mass General Hospital, Harvard Medical School, and I'm excited to talk more about AI and how it's going to change our world, hopefully for the better. Dr Grouse: We're so excited to have you. The application of AI in clinical practice is such an exciting and rapidly developing topic, and I'm so pleased to have you here to talk about your article, which I found to be absolutely fascinating. To start, I'd like to hear what you hope will be the key takeaway from your article with our listeners. Dr Hadar: Yeah, thank you. The main point of the article is that AI in medicine is a tool. It's a wonderful tool that we should be cautiously optimistic about. But the important thing is for doctors, providers to be advocates on their behalf and on behalf of their patients for the appropriate use of this tool, because there are promises and pitfalls just with any tool. And I think in the article we detail a couple ways that it can be used in diagnostics, in clinical documentation, in the workflow, all ways that can really help providers. But sometimes the devil is in the details. So, we get into that as well. Dr Grouse: How did you become interested in AI and its application, specifically in the practice of neurology? Dr Hadar: When I was a kid, as most neurologists are, I was- I nerded out on a lot of sci-fi books, and I was really into Isaac Asimov and some of his robotics, which kind of talks about the philosophy of AI and how AI will be integrated in the future. As I got into neurology, I started doing research neurology and a lot of folks, if you're familiar with AI and machine learning, statistics can overlap a lot with machine learning. So slowly but surely, I started using statistical methods, machine learning methods, in some of my neurology research and kind of what brought me to where I am today. Dr Grouse: And thinking about and talking about AI, could you briefly summarize a few important terms that we might be talking about, such as artificial intelligence, generative AI, machine learning, etcetera? Dr Hadar: It's a little difficult, because some of these terms are nebulous and some of these terms are used in the lay public differently than other folks would use it. But in general, artificial intelligence is kind of the ability of machines or computers to communicate independently. It's similar to as humans would do so. And there are kind of different levels of AI. There's this very hard AI where people are worried about with kind of terminator-full ability to replicate a human, effectively. And there are other forms of narrow AI, which are actually more of what we're talking about today, and where it's very kind of specific, task-based applications of machine learning in which even if it's very complex, the AI tools, the machine learning tools are able to give you a result. And just some other terms, I guess out there. You hear a lot about generative AI. There's a lot of these companies and different algorithms that incorporate generative AI, and that usually kind of creates something, kind of from scratch, based on a lot of data. So, it can create pictures, it can create new text if you just ask it. Other terms that can be used are natural language processing, which is a big part of some of the hospital records. When AI tools read hospital records and can summarize something, if it can translate things. So, it turns human speech into these results that you look for. And I guess other terms like large language models are something that also have come into prominence and they rely a lot on natural language processing, being able to understand human speech, interpret it and come up with the results that you want. Dr Grouse: Thank you, that's really helpful. Building on that, what are some of the current clinical applications of AI that we may already be using in our neurologic practice and may not even be aware that that's what that is? Dr Hadar: It depends on which medical record system you use, but a very common one are some of the clinical alerts that people might get, although some of them are pretty basic and they can say, you know, if the sodium is this level, you get an alert. But sometimes they do incorporate fancier machine learning tools to say, here's a red flag. You really should think about contacting the patient about this. And we can talk about it as well. It might encourage burnout with all the different flags. So, it's not a perfect tool. But these sorts of things, typically in the setting of alerts, are the most common use. Sorry, and another one is in folks who do stroke, there are a lot of stroke algorithms with imaging that can help detect where the strokes occur. And that's a heavy machine learning field of image processing, image analysis for rapid detection of stroke. Dr Grouse: That's really interesting. I think my understanding is that AI has been used specifically for radiology interpretation applications for some time now. Is that right? Dr Hadar: In some ways. Actually, my background is in neuroimaging analysis, and we've been doing a lot of it. I've been doing it for years. There's still a lot of room to go, but it's really getting there in some ways. My suspicion is that in the coming years, it's going to be similar to how anesthesiologists at one point were actively bagging people in the fifties, and then you develop machines that can kind of do it for you. At some point there's going to be a prelim radiology read that is not just done by the resident or fellow, but is done by the machine. And then another radiologist would double check it and make sure. And I think that's going to happen in our lifetime. Dr Grouse: Wow, that's absolutely fascinating. What are some potential applications of AI in neurologic practice that may be most high-yield to improve patient care, patient access, and even reduce physician burnout? Dr Hadar: These are separate sort of questions, but they're all sort of interlinked. I think one of the big aspects of patient care in the last few years, especially with the electronic medical record, is patients have become much more their own advocates and we focus a lot more on patient autonomy. So, they are reaching out to providers outside of appointments. This can kind of lead to physician burnout. You have to answer all these messages through the electronic medical record. And so having, effectively, digital twins of yourself, AI version of yourself, that can answer the questions for the patient on your off times is one of the things that can definitely help with patient care. In terms of access, I think another aspect is having integrated workflows. So, being able to schedule patients efficiently, effectively, where more difficult patients automatically get one-hour appointments, patients who have fewer medical difficulties might get shorter appointments. That's another big improvement. Then finally, in terms of physician burnout, having ambient intelligence where notes can be written on your behalf and you just need to double-check them after allows you to really have a much better relationship with the patients. You can actually talk with them one on one and just focus on kind of the holistic care of the patient. And I think that's- being less of a cog in the machine and focusing on your role as a healer would be actually very helpful with the implementation of some of these AI tools. Dr Grouse: You mentioned ambient technology and specifically ambient documentation. And certainly, this is an area that I feel a lot of excitement about from many physicians, a lot of anticipation to be able to have access to this technology. And you mentioned already some of the potential benefits. What are some of the potential… the big wins, but then also potential drawbacks of ambient documentation? Dr Hadar: Just to kind of summarize, the ambient intelligence idea is using kind of an environmental AI system that, without being very obtrusive, just is able to record, able to detect language and process it, usually into notes. So, effectively like an AI scribe that is not actually in the appointment. So, the clear one is that---and I've seen this as well in my practice---it's very difficult to really engage with the patient and truly listen to what they're saying and form that relationship when you're behind a computer and behind a desk. And having that one-on-one interaction where you just focus on the patient, learn everything, and basically someone else takes notes for you is a very helpful component of it. Some of the drawbacks, though, some of it has to do with the existing technology. It's still not at the stage where it can do everything. It can have errors in writing down the medication, writing down the exact doses. It can't really, at this point, detect some of the apprehensions and some of the nonverbal cues that patients and providers may kind of state. Then there's also the big one where a lot of these are still done by startups and other companies where privacy may be an issue, and a lot of patients may feel very uncomfortable with having ambient intelligence tools introduced into their clinical visit, having a machine basically come between the doctor and the patient. But I think that over time these apprehensions will lessen. A lot of the security will improve and be strengthened, and I think that it's going to be incorporated a lot more into clinical practice. Dr Grouse: Yeah, well, we'll all be really excited to see how that technology develops. It certainly seems like it has a lot of promise. You mentioned in your article a lot about how AI can be used to improve screening for patients for certain types of conditions, and that certainly seems like an obvious win. But as I was reading the article, I couldn't help but worry that, at least in the short term, these tools could translate into more work for busy neurologists and more demand for access, which is, you know, already, you know, big problems in our field. How can tools like these, such as, like, for instance, the AI fundoscopic screening for vascular cognitive risk factors help without adding to these existing burdens? Dr Hadar: It's a very good point. And I think it's one of the central points of why we wanted to write the article is that these AI in medicine, it's, it's a tool like any other. And just like when the electronic medical record came into being, a lot of folks thought that this was going to save a lot of time. And you know, some people would say that it actually worsened things in a way. And when you use these diagnostic screening tools, there is an improvement in efficiency, there is an improvement in patient care. But it's important that doctors, patients advocate for this to be value-based and not revenue-based, necessarily. And it doesn't mean that suddenly the appointments are shorter, that now physicians have to see twice as many patients and then patients just have less of a relationship with their provider. So, it's important to just be able to integrate these tools in an appropriate way in which the provider and the patient both benefit. Dr Grouse: You mentioned earlier about the digital twin. Certainly, in your article you mentioned, you know, that idea along with the idea of the potential of development of virtual chatbot visits or in-person visits with a robot neurologist. And I read all this with equal parts, I think excitement, but horror and and fear. Can you tell us more about what these concepts are, and how far are we from seeing technology like this in our clinics, and maybe even, what are the risks we need to be thinking about with these? Dr Hadar: Yeah. So, I mean, I definitely think that we will see implementation of some of these tools in our lifetime. I'm not sure if we're going to have a full walking, talking robot doing some of the clinical visits. But I do think that, especially as we start doing a lot more virtual visits, it is very easy to imagine that there will be some sort of video AI doctor that can serve as, effectively, a digital twin of me or someone else, that can see patients and diagnose them. The idea behind the digital twin is that it's kind of like an AI version of yourself. So, while you only see one patient, an AI twin can go and see two or three other patients. They could also, if the patients send you messages, can respond to those messages in a way that you would, based on your training and that sort of thing. So, it allows for the ability to be in multiple places at once. One of the risks of this is, I guess, overreliance on the technology, where if you just say, we're just going to have a chatbot do everything for us and then not look at the results, you really run the risk of the chatbot just recommending really bad things. And there is training to be had. Maybe in fifty years the chatbot will be at the same level as a physician, but there's still a lot of room for improvement. I personally, I think that my suspicion as to where things will go are for very simple visits in the future and in our lifetime. If someone is having a cold or something like that and it goes to their primary care physician, a chatbot or something like that may be of really beneficial use. And it'll help segment out the different groups of simple diagnosis, simple treatments can be seen by these robots, these AI, these machine learning tools; and some of the more complex ones, at least for the early implementation of this will be seen by more specialized providers like neurologists and subspecialist neurologists too. Dr Grouse: That certainly seems reasonable, and it does seem that the more simple algorithmic things are always where these technologies will start, but it'll be interesting to see where things can go with more complex areas. Now I wanted to switch gears a little bit in the article- and I thought this was really important because I see it as being certainly one of the bigger drawbacks of AI, is that despite the many benefits of artificial intelligence, AI can unfortunately perpetuate systemic bias. And I'm wondering if you could tell us a little bit more about how this happened? Dr Hadar: I know I'm beating a dead horse on this, but AI is a tool like any other. And the problem with it is that what you put in is very similar to what you get out. And there's this idea in computer science of “garbage in, garbage out”. If you include a lot of data that has a lot of systemic biases already in the data, you're going to get results that perpetuate these things. So, for instance, if in dermatologic practices, if you just had a data set that included people of one skin color or one race and you attempted to train a model that would be able to detect skin cancer lesions, that model may not be easily applicable to people of other races, other ethnicities, other skin colors. And that can be very damaging for care. And it can actually really, really hurt the treatments for a lot of the patients. So that is one of the, kind of, main components of the systemic biases in AI. The way we mitigate them is by being aware of it and actually implementing, I guess, really hard stops on a lot of these tools before they get into practice. Being sure, did your data set include this breakdown of sex and gender, of race and ethnicity? So that the stuff you have in the AI tool is not just a very narrow, focused application, but can be generalized to a large population, not just of one community, one ethnic group, racial group, one country, but can really be generalized throughout the world for many patients. Dr Grouse: The first step is being aware of it, and hopefully these models will be built thoughtfully to help mitigate this as much as possible. I wanted to ask as well, another concern about AI is the safety of private data. And I'm wondering, as we're starting to do things like use ambient documentation, AI scribe, and other types of technologies like this, what can we tell our patients who are concerned about the safety of their personal data collected via these programs, particularly when they're being stored or used with outside companies that aren't even in our own electronic medical records system? Dr Hadar: Yeah, it's a very good question, and I think it's one of the major limitations of the current implementation of AI into clinical practice, because we still don't really have great standards---medical standards, at least---for storing this data, how to analyze this data. And my suspicion is that at some point in the future, we're going to need to have a HIPAA compliance that's going to be updated for the 21st century, that will incorporate the appropriate use of these tools, the appropriate use of these data storage, of data storage beyond just PHI. Because there's a lot more that goes into it. I would say that the important thing for how to implement this, and for patients to be aware of, is being very clear and very open with informed consent. If you're using a company that isn't really transparent about their data security and their data sharing practices, that needs to be clearly stated to the patient. If their data is going to be shared with other people, reanalyzed in a different way, many patients will potentially consider not participating in an AI implementation in clinic. And I think the other key thing is that this should be, at least initially, an opt-in approach as opposed to an opt-out approach. So patients really have- can really decide and have an informed opinion about whether or not they want to participate in the AI implementation in medicine. Dr Grouse: Well, thank you so much for explaining that. And it does certainly sound like there's a lot of development that's going to happen in that space as we are learning more about this and the use of it becomes more prevalent. Now, I also wanted to ask, another good point that you made in your article---and I don't think comes up enough in this area, but likely will as we're using it more---AI has a cost, and some of that cost is just the high amount of data and computational processing needed to use it, as well as the effects on the environment from all this energy usage. Given this drawback of AI, how can we think about potential costs versus the benefits, the more widespread use of this technology? Or how should we be thinking about it? Dr Hadar: It's part of a balance of the costs and benefits, effectively, is that AI---and just to kind of name some of them, when you have these larger data centers that are storing all this data, it requires a lot of energy consumption. It requires actually a lot of water to cool these things because they get really hot. So, these are some of the key environmental factors. And at this point, it's not as extreme as it could be, but you can imagine, as the world transitions towards an AI future, these data centers will become huge, massive, require a lot of energy. And as long as we still use a lot of nonrenewable resources to power our world, our civilization, I think this is going to be very difficult. It's going to allow for more carbon in the atmosphere, potentially more climate change. So, being very clear about using sustainable practices for AI usage, whether it be having data centers specifically use renewable resources, have clear water management guidelines, that sort of thing will allow for AI to grow, but in a sustainable way that doesn't damage our planet. In terms of the financial costs… so, AI is not free. However, on a given computer, if you want to run some basic AI analysis, you can definitely do it on any laptop you have and sometimes even on your phone. But for some of these larger models, kind of the ones that we're talking about in the medical field, it really requires a lot of computational power. And this stuff can be very expensive and can get very expensive very quickly, as anyone who's used any of these web service providers can attest to. So, it's very important to be clear-eyed about problems with implementation because some of these costs can be very prohibitive. You can run thousands and you can quickly rack up a lot of money for some very basic analysis if you want to do it in a very rapid way, in a very effective way. Dr Grouse: That's a great overview. You know, something that I think we're all going to be having to think about a lot more as we're incorporating these technologies. So, important conversations I hope we're all having, and in our institutions as we're making these decisions. I wanted to ask, certainly, as some of our listeners who may be still in the training process are hearing you talk about this and are really excited about AI and implementation of technology in medicine, what would you recommend to people who want to pursue a career in this area as you have done? Dr Hadar: So, I think one of the important things for trainees to understand are, there are different ways that they can incorporate AI into their lives going forward as they become more seasoned doctors. There are clinical ways, there are research ways, there are educational ways. A lot of the research ways, I'm one of the researchers, you can definitely incorporate AI. You can learn online. You can learn through books about how to use machine learning tools to do your analysis, and it can be very helpful. But I think one of the things that is lacking is a clinician who can traverse both the AI and patient care fields and be able to introduce AI in a very effective way that really provides value to the patients and improves the care of patients. So that means if a hospital system that a trainee is eventually part of wants to implement ambient technology, it's important for physicians to understand the risks, the benefits, how they may need to adapt to this. And to really advocate and say, just because we have this ambient technology doesn't mean now we see fifty different patients, and then you're stuck with the same issue of a worse patient-provider relationship. One of the reasons I got into medicine was to have that patient-provider interaction to not only be kind of a cog in the hospital machine, but to really take on a role as a healer and a physician. And one of the benefits of these AI tools is that in putting the machine in medicine, you can also put the humanity back in medicine at times. And I think that's a key component that trainees need to take to heart. Dr Grouse: I really appreciate you going into that, and sounds like there's certainly need. Hoping some of our listeners today will consider careers in pursuing AI and other types of technologies in medicine. I really appreciate you coming to talk with us today. I think this is just such a fascinating topic and an area that everybody's really excited about, and hoping that we'll be seeing more of this in our lives and hopefully improving our clinical practice. Thank you so much for talking to us about your article on AI in clinical neurology. It was a fascinating topic and I learned a lot. Dr Hadar: Thank you very much. I really appreciate the conversation, and I hope that trainees, physicians, and others will gain a lot and really help our patients through this. Dr Grouse: So again, today I've been interviewing Dr Peter Hadar about his article on clinical applications of artificial intelligence in neurology practice, which he wrote with Dr Lydia Moura. This article appears in the most recent issue of Continuum on neuro-ophthalmology. Be sure to check out Continuum Audio episodes from this and other issues. And thank you to our listeners for joining today. Dr Monteith: This is Dr Teshamae Monteith, Associate Editor of Continuum Audio. If you've enjoyed this episode, you'll love the journal, which is full of in-depth and clinically relevant information important for neurology practitioners. Use the link in the episode notes to learn more and subscribe. Thank you for listening to Continuum Audio.

In this episode, Dr. Sara Naseri, CEO and co-founder of Qvin, shares the powerful origin story behind the Q-Pad — a revolutionary menstrual health technology transforming the way women monitor their health.Qvin is pioneering the use of menstrual blood to provide clinically relevant, accessible diagnostics for conditions like diabetes, thyroid imbalance, fertility challenges, and even cervical cancer. Dr. Naseri discusses her 10-year journey from med school to FDA clearance, the data gap in women's health, and how menstrual blood — long stigmatized and overlooked — holds incredible untapped potential for global healthcare impact.From redefining preventative care to making diagnostics available at home, this conversation is a deep dive into innovation, accessibility, and the future of femtech.Timestamps & Sections:(00:00) - Introduction & Background Dr. Sara Nasseri, CEO and Co-Founder of Qvin, introduces the company and its mission to empower women's health through the Q-Pad—a revolutionary diagnostic menstrual pad.(01:00) - Origin of the Idea Sara shares how the concept of using menstrual blood for diagnostics was born during medical school and the long journey that followed.(04:00) - Diagnostic Utility of Menstrual Blood Discussion of early research, the lack of existing data on menstrual blood, and Qvin's role in pioneering this new area of science.(07:00) - The Q-Pad's Functionality & Empowerment How the Q-Pad works, and why accessibility, affordability, and user empowerment are core to its design.(09:00) - Clinical Applications & FDA Clearance Details on the Q-Pad's FDA clearance for hemoglobin A1c monitoring and its ability to support chronic condition management like diabetes.(13:00) - Expanding Use Cases: Cervical Cancer & Beyond Exploration of new biomarkers and the potential for non-invasive cervical cancer screening through the Q-Pad.(17:00) - Tracking Fertility, Thyroid, and Inflammation Future plans to roll out clinical-grade insights into fertility windows, hormone levels, inflammation, and perimenopause—based on strong patient demand.(22:00) - App Integration & Doctor Collaboration How the app provides users with insights, tracks health trends over time, and creates doctor-ready lab reports for easy sharing.(30:00) - Mission, Team & Global Impact Sara talks about the Qvin team's resilience, the mission to close the gender data gap, and their vision of transforming women's health globally.Key Points:• The Q-Pad enables women to collect menstrual blood at home for lab testing • FDA-cleared for Hemoglobin A1C, offering diabetes insights (Type 1 & Type 2) • Cervical cancer detection using menstrual blood could be a game-changer • Clinically validated biomarkers include fertility hormones, thyroid, inflammation, cholesterol, and vitamins • App integration allows women to track biomarkers and easily share lab reports with doctors • Built for convenience: wear like a normal pad, mail sample with prepaid return, results in one week • Accessible pricing matches average U.S. co-pays and is HSA-approved • 400+ unique proteins in menstrual blood — a largely untapped diagnostic resource • Global potential: useful in areas without regular access to doctors or labsNotable Quotes:“Menstrual blood is the most overlooked opportunity in women's health.” – Dr. Sara Naseri “We've been throwing away something that could save lives.” “No woman today should die of cervical cancer — we have the tools, we just need access.” “Be active in designing the future we want.”

In this episode of Conversations in Lung Cancer Research, Dr. Malinda Itchins, Dr. Annie Wong, and A/Prof Stephen Kao discuss the concept of liquid biopsy, its advantages and limitations, and its clinical applications in lung cancer treatment. They explore how liquid biopsy can provide faster diagnosis and treatment options, especially for patients who cannot undergo traditional tissue biopsies. However, they also address the challenges of sensitivity and the need for further research to integrate liquid biopsy into routine clinical practice.This episode is sponsored by: AstraZeneca  Daiichi Sankyo Australia  SOPHiA Genetics  Thermo Fisher Scientific(00:00) Introduction and Acknowledgements(01:16) Meet the Experts(02:10) Understanding Liquid Biopsy(03:01) Advantages of Liquid Biopsy(06:21) Limitations of Liquid Biopsy(09:15) Clinical Scenarios for Liquid Biopsy(13:15) Barriers and Future Directions(19:39) Conclusion and Thank You

This podcast is brought to you by Outcomes Rocket, your exclusive healthcare marketing agency. Learn how to accelerate your growth by going to outcomesrocket.com Microsoft's use of AI and technological advances to reduce nurses' documentation burdens, improve patient care, and address the challenges of AI adoption in healthcare. In this episode, Allison Stalla, Director of Clinical Applications at Microsoft Cloud for Healthcare, talks about Microsoft's technological advances aimed at reducing nurses' documentation burdens and highlights AI's potential to ease their workloads. She shares insights into her healthcare technology background, the impact of AI on reducing nurse burnout, and the importance of change management and data literacy for AI adoption. Allison also emphasizes Microsoft's collaborative efforts with Nuance and their development partners, showcasing nurse-centered technologies and ambient voice technology pilots to aid bedside documentation. Tune in and discover how AI is transforming healthcare by reducing nurses' documentation burdens and enhancing patient care. Resources: Connect with and follow Allison Stalla on LinkedIn. Follow Microsoft on LinkedIn. Visit the Microsoft Cloud for Healthcare website and check out their blogs.  Fast Track Your Business Growth: Outcomes Rocket is a full service marketing agency focused on helping healthcare organizations like yours maximize your impact and accelerate growth. Learn more at outcomesrocket.com

Welcome to an episode where we explore the cutting-edge world of photobiomodulation (PBM) and its potential to transform the landscape of neurodegenerative disease treatment. This episode features an in-depth interview with Liam Pingree, CEO of Neuronic, we dive into the science behind PBM and the innovative Neuradiant 1070 device. Building on our discussion from last year, we'll uncover how this non-invasive therapy leverages red and near-infrared light to enhance brain health, with a focus on conditions like Alzheimer's and Parkinson's. Photobiomodulation, often called low-level laser or red light therapy, is gaining traction as a promising approach to tackle the mitochondrial dysfunction and inflammation that drive neurodegenerative diseases. Today, we'll hear from Liam about how the Neuradiant 1070, with its unique 1070 nm wavelength, aims to penetrate deeper into the brain, offering hope for symptom relief and possibly slowing disease progression. We'll also spotlight the contributions of key researchers, including Professor Paul Chazot, whose work on neuroinflammation ties into this field, alongside pioneers like Michael R. Hamblin driving PBM research forward. Join us as we break down the device's features, clinical applications, and real-world user experiences, all while peering into the future of PBM as a potential standard in brain health care. Whether you're a science enthusiast, a caregiver, or someone curious about innovative therapies, this episode offers a compelling look at how light might just shine a new path forward for neurodegenerative challenges. Let's dive in! What You'll Learn in This Episode: The Science of Photobiomodulation (PBM): Understand how PBM uses red and near-infrared light to boost mitochondrial function, reduce inflammation, and promote neurogenesis, with insights into its relevance for Alzheimer's and Parkinson's. The Neuradiant 1070 Device: Explore the specifics of this home-use PBM device, including the significance of its 1070 nm wavelength for brain penetration and its quadrant control system for targeted treatment. Key Research Contributions: Learn about the work of leading researchers like Michael R. Hamblin, John Mitrofanis, and Paul Chazot, whose studies on PBM and neuroinflammation are shaping the field. Clinical Applications and Future Vision: Discover how the Neuradiant 1070 is being used for neurodegenerative conditions, supported by emerging clinical trials, and hear Liam Pingree's vision for PBM's role in prevention and treatment by 2027.

In today's episode, Gina interviews Deb Dana, LCSW, a clinician and author who has implemented polyvagal theory to help heal individuals suffering with complex trauma. Polyvagal theory is highly applicable to individuals suffering with anxiety and Deb's knowledge and experience shine through in this interview to help listeners learn about its core concepts. Listen in today and begin to feel safe again! Learn more about Deb Dana's work at http://rhythmofregulation.com The Glimmers Journal https://amzn.to/3Dok3F4 Share your Glimmers with us https://ginaryan.gumroad.com/l/cvCTD Please visit our Sponsor Page to find all the links and codes for our awesome sponsors! https://www.theanxietycoachespodcast.com/sponsors/ Thank you for supporting The Anxiety Coaches Podcast. FREE MUST-HAVE RESOURCE FOR Calming Your Anxious Mind 10-Minute Body-Scan Meditation for Anxiety Anxiety Coaches Podcast Group Coaching link ACPGroupCoaching.com To learn more, go to: Website https://www.theanxietycoachespodcast.com Join our Group Coaching Full or Mini Membership Program Learn more about our One-on-One Coaching What is anxiety? Find even more peace and calm with our Supercast premium access membership: For $5 a month, all episodes are ad-free! https://anxietycoaches.supercast.com/ Here's what's included for $5/month: ❤ New Ad-Free episodes every Sunday and Wednesday ❤ Access to the entire Ad-free back-catalog with over 600 episodes ❤ Premium meditations recorded with you in mind ❤ And more fun surprises along the way! All this in your favorite podcast app! Chapters 0:42 Welcome to the Podcast 1:58 Exploring Glimmer's Journal 8:04 Understanding Polyvagal Theory 12:13 The Nervous System Explained 15:38 Co-Regulation and Connection 17:14 Conclusion and Next Steps Summary In this episode of the Anxiety Coaches Podcast, host Gina Ryan welcomes special guest Deb Dana, a licensed clinical social worker, clinician, consultant, and leading expert on complex trauma, who specializes in Polyvagal Theory. Deb Dana is not only a respected author of several influential books, including "Polyvagal Prompts" and "Polyvagal Exercises for Safety and Connection," but she is also a co-editor of "Clinical Applications of the Polyvagal Theory" with Dr. Stephen Porges. The discussion centers around her new book, "Glimmer's Journal," which encourages readers to reflect on the small moments that foster joy, safety, and connection—core themes that resonate deeply with the podcast's mission. Gina dives straight into Deb's journey, highlighting how she encountered Dr. Porges' work and realized the vital role the body and nervous system play in psychotherapy. Deb recounts the pivotal moment when she first read Dr. Porges' book, likening it to finding a missing piece of the puzzle in her understanding of the human experience. She shares how her initial outreach led to a collaborative workshop with Dr. Porges, which opened the door for her to incorporate Polyvagal Theory into clinical practice and ultimately inspired the tools and frameworks she has developed. The conversation explores key concepts of Polyvagal Theory, particularly the significance of safety and the role of the nervous system in our daily lives. Deb explains the concept of neuroception, describing how our nervous systems constantly assess safety and danger based on both internal cues—such as physical sensations and emotional states—and external cues from our environment and interactions with others. She emphasizes that an understanding of these dynamics can empower individuals to discern their feelings of anxiety and recognize them as adaptive survival responses rather than indications of personal failure. #mentalwellness #selfcare #wellbeing #emotionalhealth #innerpeace #healing #resilience #mindbodyconnection #polyvagalinformed #polyvagalpractice #panicattacks #overwhelm #copingskills #ACP #AnxietyCoachesPodcast #GinaRyan Learn more about your ad choices. Visit megaphone.fm/adchoices

In this week's podcast, we will provide updates the emerging roles of circulating tumor DNA (ctDNA) in managing colorectal cancer.... The post Evaluating the Clinical Applications of ctDNA in Colorectal Cancer appeared first on VJOncology.

About Dr Adeel Khan, MD - CEO and Founder of Eterna Health Interventional Cell and GeneTherapy Specialist: Dr. Adeel Khan, MD, is a trailblazer in regenerative medicine, transforming how we think about health, longevity, and recovery. As a Canadian Board-Certified Physician, Dr. Khan has pioneered cutting-edge therapies using stem cells and peptides—modalities now making headlines around the globe. Recognized worldwide, Dr. Khan's impact resonates among healthcare professionals, elite athletes, and individuals from diverse walks of life. His groundbreaking treatments have earned him the trust of renowned figures, including celebrities, such as Chris Hemsworth, life coach Tony Robbins, Chris Bumstead (popularly known as “cbum,” a top fitness influencer), and Mohamed Alabbar, the visionary developer behind the iconic Burj Khalifa. Dr. Khan's work is being discussed across major media outlets, with a focus on the potential of stem cell therapies to redefine healthcare. His ability to deliver real results is changing the conversation on what's possible in modern medicine. Dr. Khan's unwavering dedication to understanding cellular physiology and the art of cellular repair has led to collaborations with scientists in Canada, the USA, Mexico, Dubai, Italy, and Japan. These partnerships have helped shape Eterna Health, a revolutionary concept in specialized healthcare offering unparalleled treatment options that stand out in the medical landscape. Connect with Dr. Khan: Website: Eterna Health Instagram: @dr.akhan YouTube: Doctor Adeel Episode Summary: In this episode, Dr. Cassie Smith hosts Dr. Adeel Khan, a Canadian board-certified physician specializing in regenerative medicine, to discuss stem cells. Dr. Khan explains the unique properties of stem cells, particularly mesenchymal stem cells (MSCs), and their potential to treat chronic diseases, aging, and cosmetic issues. The conversation covers the science behind stem cells, their therapeutic applications, and the limitations of conventional medicine. Dr. Khan also addresses ethical concerns, regulatory challenges, and the future of stem cell research, emphasizing the transformative potential of regenerative medicine. Show Highlights: (00:02:35) Frustration with Conventional Medicine (00:04:46) Understanding Stem Cells (00:05:49) The Role of Stem Cells in Healing (00:06:27) Stem Cells and Aging (00:11:34) Clinical Applications of Stem Cells (00:14:54) Common Uses for Stem Cell Treatments (00:16:13) Stem Cells are Transforming Cosmetic Procedures (00:18:36) Stem Cells are the Body's Super Repairman (00:19:00) Smart Stem Cells?? They're Amazing! (00:20:52) Unbelievable Patient Results with Stem Cells (00:24:39) Stem Cells for Healing Autoimmune Conditions (00:29:30) FDA Regulations on Stem Cells (00:39:02) Potential of Stem Cells in Healing (00:46:24) Can Stem Cells Render Transplants Obsolete? (00:52:04) Future of Medicine with Stem Cells Connect with Modern Endocrine: Check out the⁠⁠⁠⁠⁠⁠⁠ ⁠website⁠⁠⁠⁠⁠⁠⁠⁠ Follow Cassie on⁠⁠⁠⁠⁠⁠⁠ ⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠ Follow Cassie on⁠⁠⁠⁠⁠⁠⁠ ⁠Facebook⁠⁠⁠⁠⁠⁠⁠⁠ Follow Cassie on⁠⁠⁠⁠⁠⁠⁠ ⁠YouTube⁠⁠⁠⁠⁠⁠⁠⁠ Follow Cassie on⁠⁠⁠⁠⁠⁠⁠ ⁠TikTok⁠⁠⁠⁠⁠⁠⁠⁠ Sign up for Modern Endocrine's⁠⁠⁠⁠⁠⁠⁠ ⁠newsletter⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠Disclaimer ⁠⁠⁠⁠

Jen is a 1999 graduate of the University of South Dakota with degrees in Nursing, Psychology and Dental Hygiene. Jen received her master's degree in dental hygiene from the University of Minnesota in 2013. She was previously an adjunct professor of dental hygiene at the University of Minnesota where she lectured, worked hands on with dental, dental therapy and dental hygiene students and conducted research. Jen also spent time as an investigator for the Office of the Minnesota Attorney General specializing in investigations of health care providers. She has been a licensed dental hygienist since 1999. Jen joined 3M (now Solventum) in 2016 and is currently an Advanced Clinical Applications Specialist for the Prevention Lab within Solventum where she is a subject matter expert and assures that dental products are useful and practical for dental professionals.

Text Dr. Lenz any feedback or questions Exploring GLP-1 Agonists: A Game Changer for Weight Loss and Chronic Pain?This is the 3rd episode in the ongoing series on obesity and chronic pain continuing with a discussion on GLP-1 agonists and their impact on chronic pain, specifically fibromyalgia and osteoarthritis. The role of GLP-1 agonists like semaglutide in managing diabetes and obesity, their mechanisms of action, and clinical applications is discussed. A recent study from the New England Journal of Medicine detailing the effects of semaglutide on weight loss and osteoarthritis pain is analyzed, highlighting significant improvements in patients with obesity and knee osteoarthritis. The importance of long-term use, potential side effects, and the need for an integrated approach incorporating diet and exercise are also discussed. The episode concludes with the anticipation of next week's guest, Dr. Michael Greger, who will discuss the benefits of a whole food plant-based diet as an alternative to GLP-1 agonists.00:00 Introduction to the Podcast and Weight Loss Series00:55 Exploring GLP-1 Agonists02:05 How GLP-1 Agonists Work03:42 Clinical Applications and Benefits04:19 Challenges and Considerations09:18 GLP-1 Agonists and the Gut Microbiome11:55 Effectiveness of GLP-1 Agonists18:10 Study on Semaglutide and Osteoarthritis30:10 Conclusion and Next Episode Preview Support the showA Fibromyalgia Starter Pack, which is a great companion to the book Conquering Your Fibromyalgia, is now available. Dr. Michael Lenz practices general pediatrics and internal medicine primary care, seeing patients from infants through adults. In addition, he also will see patients with fibromyalgia and related problems and patients interested in lifestyle medicine and clinical lipidology. To learn more, go to ConquringYourFibromyalgia.com. Remember that while Dr. Lenz is a medical doctor, he is not your doctor. All of your signs and symptoms should be discussed with your own physician. He aims to weave the best of conventional medicine with lifestyle medicine to help people with chronic health conditions live their best lives possible. Dr. Lenz hopes that the podcast, book, blog, and website serve as a trusted resource and starting point on your journey of learning to live better with fibromyalgia and related illnesses.

Iman Kashif from the University of Ottawa interviewed Dr. Barbara Vanderhyden, a senior scientist in ovarian cancer research and a professor at the University of Ottawa. In this insightful episode, Dr. Vanderhyden discusses her groundbreaking research pertaining to how immune regulator NLRC5 can reshape the tumor microenvironment and increase T-cell reactivity to better recognize and respond to cancer cells. She explains the mechanisms of immune evasion in ovarian cancer and discusses how her work could pave the way for novel therapeutic approaches. Learn more: https://www.ohri.ca/profile/vanderhydenlab/profile1:47 | Immune Evasion and NLRC5.4:49 | Clinical Applications of NLRC5.6:28 | Combination Therapy with NLRC5.9:23 | Tumor Adaptation Challenges. 12:26 | Advice for Early Career Professionals.Music Credit/Copyright information: Copyright free, Youtube video: “DEATH NOTE - L THEME SONG (RIFTI BEATS REMIX) [No Copyright Music]”. Account: Kingdom Power Music. Published January 18, 2021. https://www.youtube.com/watch?v=AkFHNQELp3Y&ab_channel=KingdomPowerMusicIman Kashif (Host, Audio Master), Jacqueline Aoun (Producer), Aaya Mahdi (Content Writer), Shreya Padhy (Content Writer)

In this episode of the Braun Performance & Rehab Podcast, Dan is joined by Mark Jamison to discuss the Oro Muscles device and clinical applications in performance and rehab settings. Mark Jamison joined the SIUE staff as the Head Strength and Conditioning Coach in June 2016. He was elevated to Assistant Athletic Director for High Performance in August 2019. Jamison came to SIUE after spending the three years as the Assistant Director of Sport Performance at Bradley. He also has experience at two other NCAA Division I institutions – Eastern Washington and Iowa. At Bradley, Jamison designed and implemented all phases of strength and conditioning for several sports. That included working collaboratively with Sports Medicine, Athletic Training and Physical Therapy to provide a holistic approach to student-athlete health and wellness. Prior to joining Bradley, Jamison was a strength and conditioning specialist from 2010 to 2013 at Performance Sport and Speed in Coralville, Iowa, where he designed and implemented strength and speed programs for more than 100 athletes. He implemented functional movement screening and designed corrective interventions.He spent nearly one year in the strength and conditioning department at the University of Iowa where he designed and implemented all phases of strength and conditioning for Iowa women's and men's cross country. He also worked with Iowa's track and field, softball, baseball, soccer and basketball teams. In 2013, he joined Eastern Washington as a graduate assistant. He oversaw and assisted in the strength and conditioning programs for basketball, soccer, volleyball, tennis and track and field. Jamison is a certified Strength and Conditioning Specialist through the National Strength and Conditioning Association as well as a certified Corrective Exercise Specialist through the National Academy of Sports Medicine. He earned a bachelor of arts in health and sport studies at Iowa (2010). He did a graduate assistantship at Eastern Washington and obtained his master's in rehabilitation sciences from California University of Pennsylvania (2015). Mark and his wife, Meghan, have two children, Beau and Chase For more on Mark & Oro, be sure to check out @coachjamisonhpc & @oro.muscles *SEASON 5 of the Braun Performance & Rehab Podcast is brought to you by Isophit. For more on Isophit, please check out isophit.com and @isophit -BE SURE to use coupon code BraunPR25% to save 25% on your Isophit order! **Season 5 of the Braun Performance & Rehab Podcast is also brought to you by Oro Muscles. For more on Oro, please check out www.oromuscles.com Episode Affiliates: MoboBoard: BRAWNBODY10 saves 10% at checkout!AliRx: DBraunRx = 20% off at checkout! https://alirx.health/MedBridge: https://www.medbridgeeducation.com/brawn-body-training or Coupon Code "BRAWN" for 40% off your annual subscription! CTM Band: https://ctm.band/collections/ctm-band coupon code "BRAWN10" = 10% off! Ice shaker affiliate link: https://www.iceshaker.com?sca_ref=1520881.zOJLysQzKeMake sure you SHARE this episode with a friend who could benefit from the information we shared! Check out everything Dan is up to by clicking here: https://linktr.ee/braun_prLiked this episode? Leave a 5-star review on your favorite podcast platform --- Support this podcast: https://podcasters.spotify.com/pod/show/daniel-braun/support

While cleaning up your closet can clear your mind, cleaning up your cellular habitat can change your life. This week, I'm joined by Dr. David Haase, who specializes in integrative holistic medicine and is the founder of the Maxwell Clinic in Tennessee. We sat down to discuss neurofeedback, diagnosing head injuries, and how plasma exchange (aka "an oil change" for cells) can help optimize your brain health and enhance your well-being in the long run. In this episode, you'll discover: The Science of Brain Injuries: "When the brain gets injured, the blood vessels get damaged… You no longer have the amount of vascular supply to the neurons," says Dr. Haase, adding that around 80% of people suffer from a "meaningful head injury." Fortunately, an isolated injury doesn't necessarily mean your entire brain is hurt. "One area of the brain getting injured may not come out as a deficit, but you have decreased your brain ability to be maximally resilient and maximally efficient." This is where neurofeedback comes in. What Is Neurofeedback: "Neurofeedback is a way of retraining the brain to be more electrically efficient," says Dr. Haase. This brain training, which involves measuring the electricity coming off your scalp, shows how your brain reacts to certain stimuli. This feedback can help train the brain to adjust its learning pattern naturally, thus improving focus, mood, migraines, and seizures. "If the brain gets more efficient, everything else can start to improve," he adds. Why Habitat-Optimizing Plasma Exchange Is a Game Changer: Dr. Haase is a pioneer of Habitat-Optimizing Plasma Exchange (HOPE), an intravenous treatment that cleans and replaces your plasma to improve your cellular habitat. "This process of 'oil change' for the blood decreases the rate at which Alzheimer's proceeds by over 60%," he says of the highly individualized method. "It is the single most powerful single therapy, especially for moderate Alzheimer's disease that exists." 05:46 The Role of Brain Function in Health 15:44 Understanding Neurofeedback 24:06 Diagnosing Brain Injuries and Their Impact 28:25 The HOPE Program and Cellular Health 30:23 Understanding Toxins and Nutrient Deficiencies 30:35 Aphoresis: The Oil Change for the Body 32:12 Mechanism of Action: Optimizing the Habitat 33:55 Clinical Applications and Success Stories 36:16 Procedure Details and Safety Measures 37:33 Plasma Exchange for Various Conditions 50:39 Insurance and Cost Considerations Connect with Dr. Myers: Website: https://www.amymyersmd.com/ Newsletter: https://www.amymyersmd.com/ec/guide-to-leaky-gut Facebook: https://www.facebook.com/AmyMyersMD Instagram: https://www.instagram.com/amymyersmd/ Connect with Dr. Haase: Website: https://maxwellclinic.com/ Phone number of the Maxwell Clinic: (615) 3700091 Instagram: https://www.instagram.com/maxwellclinic/ Facebook: https://www.facebook.com/maxwellclinic YouTube: https://www.youtube.com/channel/UCQq0FWvHt95ItFuVvpfMvbA X (formerly Twitter): https://twitter.com/maxwellclinic Linkedin: https://www.linkedin.com/in/davidhaasemd/

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/ZDG865. CME/MOC/AAPA credit will be available until November 13, 2025.Renewed Optimism for Personalized Care in Advanced Pancreatic and Extra-Pancreatic Neuroendocrine Tumors: The Evolving Role and Clinical Applications of Emerging Strategies to Improve Patient Outcomes In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported by medical education grants from Exelixis, Inc. and Novartis Pharmaceuticals Corporation.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/ZDG865. CME/MOC/AAPA credit will be available until November 13, 2025.Renewed Optimism for Personalized Care in Advanced Pancreatic and Extra-Pancreatic Neuroendocrine Tumors: The Evolving Role and Clinical Applications of Emerging Strategies to Improve Patient Outcomes In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported by medical education grants from Exelixis, Inc. and Novartis Pharmaceuticals Corporation.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/ZDG865. CME/MOC/AAPA credit will be available until November 13, 2025.Renewed Optimism for Personalized Care in Advanced Pancreatic and Extra-Pancreatic Neuroendocrine Tumors: The Evolving Role and Clinical Applications of Emerging Strategies to Improve Patient Outcomes In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported by medical education grants from Exelixis, Inc. and Novartis Pharmaceuticals Corporation.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/ZDG865. CME/MOC/AAPA credit will be available until November 13, 2025.Renewed Optimism for Personalized Care in Advanced Pancreatic and Extra-Pancreatic Neuroendocrine Tumors: The Evolving Role and Clinical Applications of Emerging Strategies to Improve Patient Outcomes In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported by medical education grants from Exelixis, Inc. and Novartis Pharmaceuticals Corporation.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/ZDG865. CME/MOC/AAPA credit will be available until November 13, 2025.Renewed Optimism for Personalized Care in Advanced Pancreatic and Extra-Pancreatic Neuroendocrine Tumors: The Evolving Role and Clinical Applications of Emerging Strategies to Improve Patient Outcomes In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported by medical education grants from Exelixis, Inc. and Novartis Pharmaceuticals Corporation.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/ZDG865. CME/MOC/AAPA credit will be available until November 13, 2025.Renewed Optimism for Personalized Care in Advanced Pancreatic and Extra-Pancreatic Neuroendocrine Tumors: The Evolving Role and Clinical Applications of Emerging Strategies to Improve Patient Outcomes In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported by medical education grants from Exelixis, Inc. and Novartis Pharmaceuticals Corporation.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/ZDG865. CME/MOC/AAPA credit will be available until November 13, 2025.Renewed Optimism for Personalized Care in Advanced Pancreatic and Extra-Pancreatic Neuroendocrine Tumors: The Evolving Role and Clinical Applications of Emerging Strategies to Improve Patient Outcomes In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported by medical education grants from Exelixis, Inc. and Novartis Pharmaceuticals Corporation.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA information, and to apply for credit, please visit us at PeerView.com/ZDG865. CME/MOC/AAPA credit will be available until November 13, 2025.Renewed Optimism for Personalized Care in Advanced Pancreatic and Extra-Pancreatic Neuroendocrine Tumors: The Evolving Role and Clinical Applications of Emerging Strategies to Improve Patient Outcomes In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis educational activity is supported by medical education grants from Exelixis, Inc. and Novartis Pharmaceuticals Corporation.Disclosure information is available at the beginning of the video presentation.

About Allison Stalla:Allison Stalla is a distinguished leader in the realm of healthcare technology, currently holding the position of Director of Clinical Applications at Microsoft Cloud for Healthcare. With a robust focus on reducing the documentation burdens faced by nursing clinicians, Allison utilizes cutting-edge AI technologies to enhance patient care and mitigate nurse burnout. Her comprehensive background includes significant contributions at Nuance Communications as the Principal of Client Insights, where she influenced healthcare strategy and client engagement. Allison is dedicated to advancing clinical applications that prioritize user-centric design, integrating AI into healthcare workflows, and driving digital transformation in healthcare settings.In her role at Microsoft, Allison emphasizes the importance of change management and data literacy for successful AI adoption in healthcare. She is deeply committed to fostering a collaborative environment where healthcare professionals can thrive. Her efforts are particularly concentrated on creating nurse-centered technologies, ensuring that the tools developed are not only innovative but also practical and beneficial for everyday clinical use. Through strategic partnerships and pilot programs, Allison's work at Microsoft continues to push the boundaries of what's possible in healthcare technology, ultimately aiming to improve patient outcomes and streamline clinical processes.Things You'll Learn:AI is significantly reducing documentation burdens for nurses, allowing them to focus more on patient care and reducing burnout.Despite concerns about AI replacing jobs, there's broad willingness across various age groups to adopt AI in nursing.Successful AI adoption in healthcare requires strong leadership support, effective change management, and enhanced data literacy among healthcare professionals.Involving nurses in the development and design process of AI tools is crucial for building trust and ensuring these tools meet their needs.Microsoft's collaboration with Nuance and nine development partners focuses on creating nurse-centered technologies, including piloting ambient voice technology to aid bedside documentation.Resources:Connect with and follow Allison Stalla on LinkedIn.Follow Microsoft on LinkedIn.Visit the Microsoft Cloud for Healthcare website and check out their blogs. 

In this episode of Clocking Out, host Raymond Lee sits down with Tammi Marks, a seasoned healthcare professional who recently took a bold step toward fulfilling her lifelong passion. After a 30-year career spanning clinical roles and healthcare IT, Tammi found herself at a crossroads when she was unexpectedly laid off from her position at Common Spirits. Rather than letting this setback define her, she embraced it as an opportunity to "clock out" of her former role and dive into something she had always dreamed of: aesthetics.In this episode, Tammi shares her candid experience with the challenges of being laid off, offering valuable insights on navigating career redirection with resilience and optimism. Since January 2023, she has built a thriving business in aesthetics, becoming certified in neuromodulators and fillers and learning from industry experts. Tammi's journey from OR Nursing and Clinical Informaticist roles to entrepreneurship in aesthetics is a powerful example of how embracing uncertainty can lead to unexpected fulfillment.Tune in to hear how Tammi transformed a moment of loss into an inspiring new chapter, carving her path with passion and purpose. This conversation is perfect for anyone looking to make a career pivot or turn a challenging setback into an opportunity for growth.LinkedIn: www.linkedin.com/in/tammi-marks-it-healthcare-leader-remoteInstagram: https://www.instagram.com/beauty_marks_aesthetics/Facebook: https://www.facebook.com/BeautyMarksAestheticsIdaho/Website:  www.beautymarksaesthetics.comFollow Careerminds: LinkedIn: https://www.linkedin.com/company/careermindsInstagram: https://www.instagram.com/careerminds/Facebook: https://www.facebook.com/CareermindsYoutube: https://www.youtube.com/@CareermindsVisit Raymond's website: https://www.raymondlee.co/Order Clocking Out: A Stress-Free Guide to Career Transitions: https://www.amazon.com/Clocking-Out-Stress-Free-Career-Transitions/dp/1586446541 Follow Raymond: LinkedIn: https://www.linkedin.com/in/raymondmlee/Instagram: https://www.instagram.com/raymondlee.coTiktok: https://www.tiktok.com/@clockingoutpodX: http://twitter.com/hrentrepreneurYoutube: https://www.youtube.com/@clockingoutwithraymondlee/videosBecome a guest on Clocking Out: https://docs.google.com/forms/d/e/1FAIpQLSeSTQmww_Gvld1zfLzTmS16PDfZvltFna7Gh6iSYehL-maUvA/viewform

In this week's episode of the Unreal Results podcast, I discuss the importance of feeling instead of thinking.  I recently took a course from the Barral Institute with one of my favorite instructors, Ron Mariotti, all about visceral vascular manipulation.  Ron has been an integral part of how and what I teach with the LTAP™  because he's one of the main instructors who taught me how to be better at listening to the body with my hands.  In the episode, you'll hear how a technique that was used on me has relieved digestive issues I've been having since September, the importance of going gentle on the pancreas, and why you shouldn't blame your client's body type if you're having a hard time feeling with your hands.Resources Mentioned In This EpisodeEpisode 15: Hard No To Hard Tools In The GutEpisode 36: Listening To The BodyEpisode 72: Don't Be So Hard On Yourself: The Power Of Soft ToolsConnect with Susannah on IG HERERon's Book, Physiological & Clinical Applications of Visceral Manipulation, Vol 1: The AbdomenRon's Book, Physiological & Clinical Applications of Visceral Manipulation, Vol 2: The AbdomenBarral Institute courses (be sure to mention I referred you to your first course!)Learn the LTAP™ In-Person in one of my upcoming coursesConsidering the viscera as a source of musculoskeletal pain and dysfunction is a great way to ensure a more true whole body approach to care, however it can be a bit overwhelming on where to start, which is exactly why I created the Visceral Referral Cheat Sheet. This FREE download will help you to learn the most common visceral referral patterns affecting the musculoskeletal system. Download it at www.unrealresultspod.com=================================================Watch the podcast on YouTube and subscribe!Join the MovementREV email list to stay up to date on the Unreal Results Podcast and MovementREV education. Be social and follow me:Instagram | Facebook | Twitter | YouTube

Are single-use diamond burs more efficient at cutting? When should we throw away a bur and pick up a fresh one? How long are they supposed to last? (it's measured in minutes!) Are expensive brands a con? Tiny, but one of the most important tools of our trade…BURS! In a world full of different identifying numbers and names, it can get confusing and even overwhelming.  https://youtu.be/Ol0_XcIbSD8 Watch PDP201 on Youtube That's why on today's episode, we welcome Günter and Marcela from Intensiv, a globally recognised manufacturer of dental burs, where they take great pride in bringing the latest tech to help make our dental procedures that much easier and effective. In this episode, we cover how diamonds are sourced, what the differences are in colours of burs and how the grain size of diamonds can change our results. There's lots of amazing tips and tricks here given by the team at Intensiv, so you'll definitely walk away from this one with something new up your sleeve. HIGHLIGHTS of this Episode: 01:24 Protrusive Dental Pearl 02:03 Introduction to Team Intensiv 05:40 Understanding Bur Codes 10:49 Bur Colours 15:10 When to Use Different Grit Diamonds 18:40 Single Use Burs vs Reusable Burs 24:59 Sourcing Diamonds 29:18 Fixing the Diamonds to the Metal Shank 32:40 Is my bur fit for purpose? 37:30 Drilling Zirconia 39:30 Final Tips 41:20 Contact Intensiv This episode is eligible for 0.75 CE credit via the quiz below. AGD Code: 250 Operative (restorative) Dentistry (Preparation Technology) GDC Learning Outcome:  C Learning Outcomes Identify the appropriate dental burs for different procedures, considering grit size and material composition, to ensure efficient and safe treatment. Evaluate the impact of bur selection on patient comfort and procedural outcomes, minimising trauma and maximising efficiency during dental treatments. Implement best practices for the maintenance and replacement of burs to ensure optimal performance and longevity, thereby improving clinical results and patient satisfaction. If you liked this episode, you will aslso like: PDP117 - Dental Ceramics in 2022 – Which Ceramic Should I Use

This episode of the Ketamine Startup Podcast, comes from a presentation Sam gave at the American College of Emergency Physicians Scientific Assembly on October 1, 2024. Discover the journey of opening a ketamine clinic, the efficacy of IV ketamine for depression, anxiety, PTSD, and chronic pain, and the mechanism behind its success. You will learn about the growing mental health crisis, high burnout rates among emergency physicians, and why ketamine therapy can be a rewarding alternative career path. Sam also shares the emotional and financial realities of running a ketamine clinic, emphasizing the importance of motivation, purpose, and personal fulfillment. Hear powerful testimonials from patients and gain practical advice for starting your own clinic. Don't miss this comprehensive guide filled with scientific studies, real-life experiences, and expert insights.What You'll Learn In This Episode:• Career Transition: Discover how emergency physicians can pivot into running ketamine clinics and find greater autonomy and purpose.• Clinical Evidence: Explore key studies supporting the use of ketamine therapy for depression, anxiety, PTSD, and chronic pain.• Overcoming Challenges: Understand the financial and emotional challenges of running a ketamine clinic and how to stay motivated by focusing on your "why."Episode 22 show notes:00:00 Teaser - The Swimming Pool Dilemma00:35 Introduction01:10 Sam's Journey and Niche in Ketamine Therapy03:12 The Mental Health Crisis05:05 Challenges Faced by Emergency Physicians06:13 Scientific Studies on IV Ketamine Therapy08:45 Ketamine for Anxiety and PTSD10:47 Ketamine for Chronic Pain12:13 How Does Ketamine Work?12:17 Ketamine's Impact on Neurotransmitters13:11 Ketamine and Chronic Stress14:06 Hallucinogenic Effects of Ketamine14:57 Emergency Medicine and Ketamine16:16 Starting a Ketamine Clinic17:19 The Importance of Your 'Why'18:33 Challenges and Rewards of a Ketamine Clinic20:12 Patient Testimonials and Impact21:34 ConclusionThanks for listening

In this episode, Kayce Degenhardt, Vice President of IT Clinical Applications at Inova Health System, discusses the integration of AI in clinical systems, application rationalization, and supporting her team's well-being. She shares her vision for improving clinician and patient experiences, along with advice for emerging healthcare leaders.

Substantial research has focused on identifying biomarkers for the diagnosis of Parkinson's disease (PD) as well as monitoring progression of the disease. In developing these biomarkers, it is critical for scientists to consider how the biomarkers will ultimately be used in the clinic and in clinical trials research. In this interview, Dr. Charles (Chuck) Adler shares his perspectives on how biomarkers are currently being used in clinical and research contexts, and what it would take for him to use them more often in clinical practice. He also discusses how groundbreaking collaborative research studies, including the Arizona Study of Aging and Neurodegenerative Disorders and the Parkinson's Progression Markers Initiative (PPMI), are having major impacts on the field. Chuck is Consultant and Professor of Neurology in the Department of Neurology and The Wayne and Kathryn Preisel Professor of Neuroscience Research at the Mayo Clinic Alix School of Medicine at the Mayo Clinic in Arizona.This podcast is geared toward researchers and clinicians. If you live with Parkinson's or have a friend or family member with PD, listen to The Michael J. Fox Foundation Parkinson's Podcast. Hear from scientists, doctors and people with Parkinson's on different aspects of life with the disease as well as research toward treatment breakthroughs at https://www.michaeljfox.org/podcasts.

Substantial research has focused on identifying biomarkers for the diagnosis of Parkinson's disease (PD) as well as monitoring progression of the disease. In developing these biomarkers, it is critical for scientists to consider how the biomarkers will ultimately be used in the clinic and in clinical trials research. In this interview, Dr. Charles (Chuck) Adler shares his perspectives on how biomarkers are currently being used in clinical and research contexts, and what it would take for him to use them more often in clinical practice. He also discusses how groundbreaking collaborative research studies, including the Arizona Study of Aging and Neurodegenerative Disorders and the Parkinson's Progression Markers Initiative (PPMI), are having major impacts on the field. Chuck is Consultant and Professor of Neurology in the Department of Neurology and The Wayne and Kathryn Preisel Professor of Neuroscience Research at the Mayo Clinic Alix School of Medicine at the Mayo Clinic in Arizona.This podcast is geared toward researchers and clinicians. If you live with Parkinson's or have a friend or family member with PD, listen to The Michael J. Fox Foundation Parkinson's Podcast. Hear from scientists, doctors and people with Parkinson's on different aspects of life with the disease as well as research toward treatment breakthroughs at https://www.michaeljfox.org/podcasts.

In this episode, we sit down with Australian homeopath Sarah Kottman to explore her journey through the world of natural healing. Sarah opens up about how discovering homeopathy as a child changed her life and led her to explore a range of healing practices, including her work with meteorite remedies like Moldavite and Shungite. She shares the personal stories and deep themes that emerged from these unique provings. We also discuss how Sarah weaves together craniosacral therapy, Reiki, and breathwork to offer truly holistic care. Plus, she gives us a peek into her upcoming adventure in the Solomon Islands, where she'll be working with local communities and bringing her homeopathic skills to new and exciting settings.   Episode Highlights: 07:14 - Sarah's Background and Homeopathy Journey 10:11 - Involvement with the AHA and International Council 11:50 - Exploring Meteorite Provings 12:50 - First Encounter with Moldavite 15:14 - Themes and Findings from Meteorite Provings 18:27 - Clinical Applications of Moldavite and Shungite 21:01 - Shungite Proving Insights 23:16 - Experiences and Challenges in Provings 31:18 - Combining Modalities in Practice 35:17 - Exciting Trip to the Solomon Islands   About my Guest: Sarah Kottmann is a Homeopath and Functional Nutritionist who has been transforming lives through natural healing since she began her practice in July 2011. With expertise in Intuitive Healing, Sound Healing, Functional Nutrition, and CranioSacral Therapy, Sarah helps clients achieve holistic wellness, addressing both physical and emotional health. Her personal journey with homeopathy, which healed her childhood asthma and eczema, inspired her deep commitment to these therapies.   Sarah has also made significant contributions to the field, serving as the AHA representative for the International Council of Homeopathy and as a national executive member of the Australian Homeopathic Association from 2017 to 2018. In 2022, she took on the role of Event/Venue Organizer for AHA conferences, reflecting her ongoing dedication to advancing natural healing practices.   Find out more about Sarah Website: https://www.northlakeshomeopathy.com.au/   If you would like to support the Homeopathy Hangout Podcast, please consider making a donation by visiting www.EugenieKruger.com and click the DONATE button at the top of the site. Every donation about $10 will receive a shout-out on a future episode.   Join my Homeopathy Hangout Podcast Facebook community here: https://www.facebook.com/groups/HelloHomies   Follow me on Instagram https://www.instagram.com/eugeniekrugerhomeopathy/   Here is the link to my free 30-minute Homeopathy@Home online course: https://www.youtube.com/watch?v=vqBUpxO4pZQ&t=438s   Upon completion of the course - and if you live in Australia - you can join my Facebook group for free acute advice (you'll need to answer a couple of questions about the course upon request to join): www.facebook.com/groups/eughom

In this episode of the EquiConnect Podcast, host Dr. Mike Pownall welcomes Dr. Esther Millares from McKee Panel Equine Services - Campbellville to discuss the emerging field of orthobiologics. The conversation delves into the definition, applications, and benefits of orthobiologics like Platelet Rich Plasma (PRP), IRAP, and ProStride for treating equine musculoskeletal issues. Dr. Millares explains how these regenerative therapies work, their advantages over traditional treatments, and common misconceptions. The episode emphasizes the importance of consulting veterinarians for proper diagnosis and personalized treatment plans.Dr Esther Millares started her professional career after graduating in 2012 in Madrid, Spain where she did an equine rotating internship at the Alfonso X El Sabio Veterinary Teaching Hospital. During this time, her interest in sport medicine and equine surgery increased and she decided to pursue a career in sports medicine.She then started a second internship at Paton & Martin Veterinary Services in Vancouver, Canada, an equine clinic with a large orthopedic and lameness caseload. During this experience, she was afforded the opportunity to work with elite sport horses that suffered a range of orthopedic injuries and allowed her to refine her lameness skills.Afterwards, she completed a two-year Equine Sports Medicine Fellowship and a one-year Equine Field service Fellowship (Junior specialist) at the Veterinary Teaching Hospital of the University of California-Davis, USA. Dr. Millares then enrolled in an Equine Sports Medicine and Rehabilitation Residency program (ACVSMR Practice Experience), completed a certification in acupuncture by the Chi Institute in Florida, and achieved a kinesiotaping certification by Equi-Tape. During her time as a fellow and resident, she was able to develop some interest in research studies, which motivated her to pursue a Master of Sciences (MSc) at the University of Montreal (UdeM). Following graduation of the MSc, she was hired as an equine clinician at the veterinary teaching hospital (CHUV) of the University of Montreal and continues collaborating as a veterinary researcher at the Equine Asthma Research Laboratory of the UdeM.During her time as a veterinarian, she has taken many different opportunities to learn and become very proficient at the diagnosis of basic and complex lameness, regenerative medicine, diagnostic imaging, routine medicine procedures, and acupuncture among others.Time Stamps:00:00 Introduction to Equi Connect Podcast00:37 Meet Dr. Esther Millares02:28 Understanding Orthobiologics04:21 Types of Orthobiologics07:40 Clinical Applications and Benefits09:43 Cost and Frequency of Treatments12:46 Myths and Misconceptions14:45 Conclusion and Final ThoughtsFor more information visit www.mckeepownall.ca or email info@mpequine.com

In this episode Anne Forsyth, Director of Clinical Applications and Support at Women's College Hospital in Canada, discusses the challenges and opportunities in optimizing healthcare IT systems, particularly in data management and digital literacy. She shares her experiences transitioning from a policy role to a hospital setting and emphasizes the importance of data governance, workflow design, and continuous improvement in digital health projects. Key Takeaways: Community and Collaboration: Canada's digital health community is a significant asset in advancing healthcare IT. AI and Data Standards: The adoption of AI in healthcare is promising but requires robust data governance and standards. Importance of Fundamentals: Good governance, workflow optimization, and training are crucial in creating sustainable healthcare IT systems. Digital Health Literacy: Clinicians need focused training on using digital tools correctly rather than deep technical knowledge. Cybersecurity Preparedness: Hospitals must prioritize business continuity planning to prepare for potential cyber attacks. www.facesofdigitalhealth.com Newsletter: https://fodh.substack.com/ Show notes: [00:04:00] Optimism in Canadian Digital Health [00:06:00] The Role of AI and Data Standards [00:08:00] Transition from Policy to Practice [00:10:00] The Fundamentals of IT in Healthcare [00:16:00] Tackling Unstructured Data [00:22:00] Continuous Improvement in Healthcare IT [00:26:00] Digital Health Literacy for Clinicians [00:34:00] Cybersecurity and Business Continuity [00:38:00] Closing Remarks and Advice The importance of strong relationships with vendors and clinicians in solving technical challenges in healthcare IT. Final thoughts on the continuous nature of digital health optimization and the need for sustainable, well-communicated strategies.

In this episode, Dr. Nikki Blaze, Assistant Vice President of Information Systems Clinical Applications at Cincinnati Children's Hospital, shares her insights on harnessing cutting-edge technology and AI to enhance clinical workflows, reduce documentation burdens, and drive transformative change.

In case you missed out on yesterday's email and/or social media announcements: the newest edition of my RLT eBook was released! This has been a long time coming and a labor of love. As decent as the previous versions have been (not trying to toot my own horn), the protocols provided in those editions were, more or less, centered around a particular light irradiance. That meant if you had a device with a different light irradiance, you would have to do some clever calculations to recalibrate your RLT treatment protocol. Thankfully, that is no longer the case.With this newest eBook that is entitled, The Red Light Guide, you now have access to my innovative RLT Treatment Protocol Ecosystem. This ecosystem essentially allows anyone with any RLT device to develop an science-backed, individualized RLT protocol based on what they are trying to treat. Out with the old rigid protocol paradigm, in with the infinitely versatile ecosystem.In today's episode, I begin reading The Red Light Therapy Guide from the very beginning, essentially providing an audiobook version of the eBook. I wade through the Important Concepts and Important Considerations (as it relates to RLT) sections of the eBook, which covers the first ~15 pages of this 130+ page PDF eBook. I will continue reading through this eBook in future solosodes to complete this audio version of the eBook so that you RLT podcast junkies can get your fill of the newest information available. Enjoy! If you found the information in today's episode particularly interesting and/or compelling, please share it with a family member, friend, colleague and/or anyone that you think could benefit and be illuminated by this knowledge. Sharing is caring :)As always, light up your health! - Key Points Introduction (00:00 - 02:00) Red Light vs. Near Infrared Light (02:00 - 04:00)Mitochondria and Red Light Therapy (04:00 - 07:00)Biphasic Dose Response (07:00 - 08:00)Hormesis and Red Light Therapy (08:00 - 09:00)Timing of Red Light Therapy Treatments (09:00 - 11:00)Treating Multiple Areas (11:00 - 12:00)Red Light Therapy Devices (12:00 - 15:00)Clinical Applications of Red Light Therapy (15:00 - 20:00)Safety and Contraindications (20:00 - 22:00)Red Light Therapy Protocols (22:00 - 28:00)Future Directions of Red Light Therapy (28:00 - 30:00)Q&A and Conclusion (30:00 - 40:00 - Introducing: The Red Light Therapy Guide eBook Producing your own red light therapy treatment protocols has never been more accurate, individualized and effortless! In this 130+ page fifth edition of Dr. Mike Belkowski's highly coveted red light therapy eBook resource, you are provided access to the requisite resources that allow you to immediately begin developing your treatment protocols.  This ground-breaking paradigm is much more nuanced and accurate than the previous version of the eBook, as every protocol will be specific to: The red light therapy device you are using What you are trying to treat Learn more & purchase The Red Light Therapy Guide by clicking here - BioLight is in the middle of making a major upgrade to the three BioBlue products that include NMN: BioBlue, BioBlue (SR) and BioBlue Leuco.   This sale will last until current BioBlue inventory is sold out. Once this sale is over, the upgraded BioBlue will resume the normal prices.    If you would like to wholesale BioBlue in quantities greater than 40 for a larger discount, please email: info@biolight.shop   Discount codes:20% off (1 - 4 bottles) = bioblue2025% off (5 - 9 bottles) = bioblue2530% off (10 - 19 bottles) = bioblue3035% off (20 - 29 bottles) = bioblue3540% off (30+ bottles) = bioblue40   *You must use the "single" option for adding to cart and can add as many bottles as desired   Shop BioBlue & save BIG! - Dr. Mike's #1 recommendations: Water products: Water & Wellness Grounding products: Earthing.com EMF-mitigating products: Somavedic Blue light-blocking glasses: Ra Optics - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn   BioLight: Website Instagram YouTube Facebook

The first mixed-reality-navigated shoulder replacement surgery in the U.S. took place in early 2024. Specialized technologies were used to create a customized life-size hologram of the patient's joint and plan the position of the replacement implants. Listen to how mixed reality improves surgical precision and may reduce complications and improve patient recovery. Featured experts include the surgeon who performed this very first surgery: Dr. Sanchez-Sotelo, Division Chair Shoulder & Elbow Surgery at Mayo Clinic; and ​​​​Jean Chaoui, VP of Clinical Applications and Solutions, Digital, Robotics and Enabling Technologies at Stryker.

Dr. Linda Chu summarizes recent review articles on NASH, liver MR elastography, and LI-RADS contrast enhanced US nonradiation treatment assessment algorithm.   Liver Imaging Reporting and Data System Contrast-Enhanced US Nonradiation Treatment Response Assessment Version 2024. Lyshchik et al. Radiology 2024; 311(2):e232369.   Interpretation, Reporting, and Clinical Applications of Liver MR Elastography. Cunha et al. Radiology 2024; 310(3):e231220.   Diagnosis and Monitoring of Nonalcoholic Steatohepatitis: Current State and Future Directions. Kadi et al. Radiology 2024; 310(1):e222695. 

In this episode of "Life, Death, and the Space Between," I engage in a captivating discussion with psychiatrist Dr. Bernard Beitman and Ruslana Markova about meaningful coincidences, or synchronicity. Inspired by Carl Jung, Dr. Bateman explains how these significant events can guide us in life. We explore the differences between synchronicity, serendipity, and surreality, and discuss the psycho sphere—a shared mental space enabling telepathic connections. Through personal stories and clinical insights, we emphasize the importance of recognizing these phenomena in both therapy and daily life.Introduction and Context (00:00:00)** Discussion on Carl Jung (00:04:15)** Importance of Noticing Coincidences (00:05:23)** Defining Coincidences (00:06:21)** Experiential Examples (00:07:23)** Coincidence Definitions (00:08:32)** Patterns of Coincidences (00:12:10)** Clinical Applications (00:15:36)** Psycho Sphere Concept (00:17:51)** Collective Consciousness (00:21:04)** Personal Connection (00:22:39)** Discussion on Family Connections (00:23:07)** Research on Coincidence Probability (00:23:34)** Reception by Medical Community (00:24:40)** Critique of Randomness (00:25:29)** Book and Project Promotion (00:25:54)** Accessing Further Work (00:26:08)** Closing Remarks (00:27:09)** **** SUPPORT DR. AMY ROBBINS: If you're enjoying the podcast and finding value in guest interviews, ghost stories, and the content I share, please consider supporting the show by becoming a Patreon member for as little as $5 a month at Patreon.com/DrAmyRobbins As a member you'll get more say in the content we cover and exclusive access to behind-the-scenes goodness! Stay Connected with Dr. Amy Robbins: ● Instagram● YouTube● Website● Facebook ***** ABOUT DR. BERNARD BEITMAN: https://simple.wikipedia.org/wiki/Bernard_D._Beitmanhttps://www.coincider.com/https://www.psychologytoday.com/intl/contributors/bernard-d-beitman-mdhttps://twitter.com/drbeitman Life, Death and the Space Between is brought to you by:Dr. Amy Robbins | Host, Executive ProducerPodcastize.net | Audio & Video Production | Hosted on Acast. See acast.com/privacy for more information.

Episode 20 - The Impact of GLP-1 Receptor Agonists with Dr Suman SrinivasaIn this episode of Going anti-Viral, Dr Michael Saag speaks with Dr Suman Srinivasa from Harvard Medical School about the impact of GLP-1 receptor agonists on diabetes and obesity. They discuss the mechanisms, benefits, and current and potential applications, including their use by people with HIV. The episode also highlights future prospects and challenges, including access to medication.00:00 Introduction01:42 Understanding GLP-1 Receptor Agonists03:19 Mechanisms and Benefits of GLP-1 Receptor Agonists05:34 Clinical Applications and Insurance Challenges09:56 GLP-1 Receptor Agonists in HIV Patients15:50 Future Prospects and Broader Applications23:37 Closing Remarks__________________________________________________Produced by IAS-USA, Going anti–Viral is a podcast for clinicians involved in research and care in HIV, its complications, and other viral infections. This podcast is intended as a technical source of information for specialists in this field, but anyone listening will enjoy learning more about the state of modern medicine around viral infections. Going anti-Viral's host is Dr Michael Saag, a physician, prominent HIV researcher at the University of Alabama at Birmingham, and volunteer IAS–USA board member. In most episodes, Dr Saag interviews an expert in infectious diseases or emerging pandemics about their area of specialty and current developments in the field. Other episodes are drawn from the IAS–USA vast catalogue of panel discussions, Dialogues, and other audio from various meetings and conferences. Email podcast@iasusa.org to send feedback, show suggestions, or questions to be answered on a later episode.Follow Going anti-Viral on: Apple Podcasts YouTube InstagramTikTok...

Send us a Text Message.Get your fermentation on whith Sarah and The Shrub covering Kombucha! Also a little story (some might say rant...) from a recent weird event, and a spicy face-off between two shrubs.***- “Kombucha” (Wikipedia). https://en.wikipedia.org/wiki/Kombucha - Zeratsky, Katherine. Mayo Clinic Consumer Health. https://www.mayoclinic.org/healthy-lifestyle/consumer-health/expert-answers/kombucha-tea/faq-20058126- MacKeen, Dawn. “Are There Benefits to Drinking Kombucha?” The New York Times, 16 Oct. 2019. https://www.nytimes.com/2019/10/16/style/self-care/kombucha-benefits.html- Maicas, Sergi. “The Role of Yeasts in Fermentation.” Microorganisms, August 2020. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7466055/#:~:text=Upon%20a%20strictly%20biochemical%20point,by%20converting%20sugar%20into%20alcohol.- Davani-Davari, Dorna; Negahdarjpour, Manica; Karimzadeh, Iman; Seifan, Mostafa; Mohkam, Milad; Masoumi, Seyed Jalil; Berenjian, Aydin; Ghasemi, Younes. “Prebiotics: Definition, Types, Sources, Mechanisms, and Clinical Applications.” Foods, March 2019. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6463098/- Grushkin, Daniel. “Meet the Woman Who Wants to Grow Clothing in a Lab.” Popular Science, 17 Feb. 2015. https://www.popsci.com/meet-woman-who-wants-growing-clothing-lab/- https://www.youtube.com/watch?v=D3Axb37lMWI- https://www.youtube.com/@YouBrewKombucha***ig: @shrubbish_podemail: shrubbishpodcast@gmail.comWhile I want to bring levity to the table, this podcast does contain descriptions of substance abuse. If you or someone you know needs help, the SAMHSA (Substance Abuse and Mental Health Services Administration) hotline is available 24/7 at 1-800-662-HELP (4357).

When it comes to choosing the right material for your veneer or crown it can get a little tricky. Lately, it's been a contest between zirconia and lithium disilicate. There are definite clinical indications for each. And the other question is do we bond or use traditional cements. To give his perspective on all this is our guest is Dr. Todd Snyder. Dr Snyder is a popular speaker on Viva Learning.com, a cosmetic dentist, international author, lecturer and consultant to dental companies. He hosts a weekly podcast, Delusional: Winning the Weekly War of Dentistry. You can reach Dr. Snyder at: www.Legion.Dentist.

Drs Michelle Kittleson and Jennifer Cowger discuss navigating the future of heart failure care through durable mechanical circulatory support, including patient selection, outcomes, and upcoming advances. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/viewarticle/997321. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals. Resources Heart Failure https://emedicine.medscape.com/article/163062-overview The Future of Durable Mechanical Circulatory Support: Emerging Technological Innovations and Considerations to Enable Evolution of the Field https://pubmed.ncbi.nlm.nih.gov/38431185/ Impact of 2018 Allocation System Change on Outcomes in Patients With Durable Left Ventricular Assist Device as Bridge to Transplantation: A UNOS Registry Analysis https://pubmed.ncbi.nlm.nih.gov/36973093/ OPTN Policy 6: Allocation of Hearts and Heart-Lungs https://unos.org/resources/heart-lung-toolkits/ The Impella Device: Historical Background, Clinical Applications and Future Directions https://pubmed.ncbi.nlm.nih.gov/31384109/#full-view-affiliation-1 INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support) Profiling Identifies Ambulatory Patients at High Risk on Medical Therapy After Hospitalizations for Heart Failure https://pubmed.ncbi.nlm.nih.gov/27834198/ Response Shift in Patient-Reported Outcomes: Definition, Theory, and a Revised Model https://pubmed.ncbi.nlm.nih.gov/33909187/ Physiology and Clinical Utility of HeartMate Pump Parameters https://pubmed.ncbi.nlm.nih.gov/34980564/ 2023 Gordon Research Seminar on Assisted Circulation (GRS): Translating Mechanical Circulatory Support from Bench to Bedside to Global Implementation https://www.grc.org/assisted-circulation-grs-conference/2023/

Hello there!Understanding hydrolyzed proteins is crucial for advancing nutritional science and crafting safer, more effective diets in the pet food industry. In this episode of The Pet Food Podcast Show, Dr. Luciano Trevizan explores the science and benefits of hydrolyzed proteins in pet diets, providing essential insights to enhance animal health. Discover how these nutrients revolutionize pet food formulations. Tune into this informative episode on your preferred streaming platform today!"Hydrolyzed proteins can significantly lower the allergenic properties of diets, benefiting sensitive pets."Meet the guest: Dr. Luciano Trevizan, a Full Professor at the Federal University of Rio Grande do Sul and Visiting Professor at the University of Guelph, specializes in pet animal nutrition. Since 2002, his research has focused on improving pet food through innovative ingredients and co-products. His laboratory collaborates with industry partners to develop and test new pet diets.What will you learn:(00:00) Highlight(01:10) Introduction (06:36) Defining Hydrolyzed Proteins(11:38) Methods of Hydrolysis(18:27) Benefits of Hydrolyzed Proteins(25:32) Clinical Applications and Digestibility(30:16) High Levels of Hydrolyzed Protein Effects(34:05) Future Research Directions(37:35) ConclusionThe Pet Food Science Podcast Show is trusted and supported by innovative companies like:* Kemin* Trouw Nutrition- Biorigin- Corbion- ADM- ProAmpac- ICC- InnovafeedAre you ready to unleash the podcasting potential of your company? wisenetix.co/custom-podcast

In this episode of the PRS Global Open Keynotes podcast, Dr. Christopher Homsy discusses the utility of the keystone island perforator flap. This episode discusses the following PRS Global Open article: The Keystone Perforator Island Flap: Review of Utility and Versatile Clinical Applications by Natalie Pawlak, Gabriel De La Cruz Ku, Abhishek Chatterjee, Sarah Persing and Christopher Homsy. Read the article for free on PRSGlobalOpen.com:https://bit.ly/KPIsApplication Dr. Christopher Homsy is an Assistant Professor in the Department of Plastic Surgery at the Tufts Medical Centre in Boston, Massachusetts. Your host, Dr. Damian Marucci, is a board-certified plastic surgeon and Associate Professor of Surgery at the University of Sydney in Australia. #PRSGlobalOpen #KeynotesPodcast #PlasticSurgery

Event Objectives:List characteristics of point-of-care ultrasonography.Identify clinical scenarios in which the use of point-of-care ultrasonography can help guide optimal management.Describe how point-of-care ultrasonography can enhance physical exam skills, augment teamwork, and inspire learners, patients, and caretakers.Claim CME credit here!

Dr. Zack Bein is a psychologist in the Dan Brown/David Elliott lineage of clinicians who believe strongly in the “3 pillar” approach to healing relational difficulty in adults. I also have clinical experience with substance abuse/dependence, anxiety disorders, mood disorders, impulse-control disorders, psychotic disorders, and several personality disorders. His research is in mindfulness treatments for addiction and posttraumatic symptoms.  At the University of California, Berkeley, Zack worked in the schizophrenia lab, examining the relationship between memory, emotions, and negative symptoms in patients with schizophrenia.His approach to therapy is integrative, considering elements from a variety of theories and modalities, as well as evidence-based practices. Some of these include Attachment Theory, mindfulness-based interventions, Humanistic/Existential Therapy, Narrative Therapy, Cognitive-Behavioral Therapy, Trauma-Focused Cognitive-Behavioral Therapy, Seeking Safety, Acceptance & Commitment Therapy (ACT), Three Pillars Therapy and the Ideal Parent Figure (IPF) Protocol.He is trained in administering and scoring the Adult Attachment Interview by Howard and Miriam Steele at the New School in Manhattan.  The AAI is the gold standard assessment of attachment styles in adults.Dr. Bein also works closely with David Elliott, Ph,D, the co-creator of the model, to teach the 3 Pillar Model to clinicians, therapists, coaches, who wish to incorporate healing of attachment disturbances in their work.  Zack is authored of an upcoming chapter in “Clinical Applications of the AAI, Part 2,” in which he details how the Three Pillars therapist uses the AAI in an ethically minded way to inform the work.

Dr. Paolo Cassano, an expert in photobiomodulation, discusses its potential in preventing cognitive decline. He traces his journey from a focus on international psychiatry to pioneering research in using light therapy for brain disorders. Photobiomodulation involves non-invasive transcranial exposure to specific wavelengths of light, particularly near-infrared light. Dr. Cassano's "aha" moment came when he observed significant improvements in patients' mental health, including reduced depression symptoms and improved cognitive function. While his current Alzheimer's study will take a few more years for conclusive results, he points out that accessible photobiomodulation devices are already available, with industry trends shifting towards more comprehensive support systems. He advises seeking reputable companies that market devices within the $1,000 range. Dr. Cassano highlights the potential for systemic effects and discusses the exciting future of this field, especially for individuals seeking alternative treatments. The interview sheds light on an emerging therapeutic approach that offers hope in the fight against cognitive decline. Here's a chapter outline with timecodes for the different topics covered in the podcast interview: Chapter 1: Introduction and Background [00:00:00] Introduction to the podcast and guest introduction (Dr. Paolo Cassano). [00:01:07] Dr. Cassano's background and how he got involved in photobiomodulation research. Chapter 2: Understanding Photobiomodulation [00:03:11] Explanation of transcranial photobiomodulation. [00:04:27] The role of specific wavelengths, such as near-infrared light. [00:05:50] The impact of light on cellular processes and mitochondria. Chapter 3: Clinical Applications and Research [00:06:09] Dr. Cassano's "aha" moment in photobiomodulation research. [00:07:44] Discussing the potential benefits for mitochondrial deficiency. [00:09:26] Current research studies, including the one at Massachusetts General Hospital. Chapter 4: Access to Photobiomodulation Devices [00:10:38] Availability of photobiomodulation devices for individuals. [00:11:48] Risks and considerations for using these devices before official results are available. [00:13:08] The timeline for when the Alzheimer's study results might be expected. Chapter 5: Current Devices and Brands [00:13:37] Discussion of LED vs. laser devices. [00:15:30] The efficacy of different wavelengths, including red light. [00:16:53] Overview of brands and considerations for choosing a device. Chapter 6: Future Developments [00:20:33] The evolving landscape of photobiomodulation devices. [00:22:23] Potential systemic effects of photobiomodulation. [00:23:08] Anticipated advancements in the field. Chapter 7: Personal Impact and Closing Remarks [00:25:42] Dr. Cassano's personal experience with photobiomodulation for a family member. [00:28:43] Excitement about the future of photobiomodulation and its potential to help people. [00:31:15] Gratitude and closing remarks. Please note that these timecodes are approximate and can be adjusted as needed based on the specific content and organization of your podcast chapters.   *****   Dr. Paolo Cassano is a distinguished figure in the field of neuropsychiatry and photobiomodulation. With a profound commitment to advancing the understanding and treatment of brain disorders, he has made significant contributions to the world of medical research and patient care.   Dr. Cassano's academic journey is marked by excellence. He holds both an MD and a PhD, a testament to his dedication to exploring the complexities of the human mind and brain. This dual expertise allowed him to bridge the gap between clinical practice and scientific inquiry seamlessly.   As the Director of Photobiomodulation at Massachusetts General Hospital and an Assistant Professor of Psychiatry at Harvard University, Dr. Cassano has played a pivotal role in pioneering photobiomodulation as a revolutionary intervention for brain disorders. His work has led to groundbreaking insights into the therapeutic potential of specific wavelengths of light, particularly near-infrared light, in stimulating brain function and alleviating conditions such as depression, anxiety, and cognitive decline.   Dr. Cassano's journey into photobiomodulation was serendipitous, driven by a desire to find alternative treatments that resonated more with his patients than traditional medication. Over the years, he has spearheaded numerous clinical studies, shedding light on the efficacy and safety of photobiomodulation devices.   His dedication extends beyond the laboratory and clinic. Dr. Cassano's personal experience, including his efforts to help family members with cognitive impairments, has deepened his commitment to making these innovative therapies more accessible to those in need.   In a rapidly evolving field, Dr. Cassano remains at the forefront, guiding the way toward a future where photobiomodulation devices offer new hope for individuals seeking relief from brain-related conditions. His work is a testament to the power of interdisciplinary research and a shining example of how science can change lives for the better.   *****   Cutting Edge Health podcast website: https://cuttingedgehealth.com/   Cutting Edge Health Social and YouTube: YouTube channel: youtube.com/@cuttingedgehealthpodcast Instagram - https://instagram.com/cuttingedgehealthpodcast Facebook - https://www.facebook.com/Cutting-Edge-Health-Podcast-with-Jane-Rogers-101036902255756   Please note that the information provided in this show is not medical advice, nor should it be taken or applied as a replacement for medical advice. The Cutting Edge Health podcast, its employees, guests and affiliates assume no liability for the application of the information discussed.   Special thanks to Alan and Maria on the Cutting Edge Health team!  

In this episode of the BackTable podcast, host Dr. Ally Baheti interviews interventional radiologist Dr. Merve Ozen about the potential of the Percunav system, an advanced needle guidance technology used in interventional and endovascular procedures. Dr. Ozen is an Assistant Professor of Radiology, Surgery, Obstetrics, and Gynecology at the University of Kentucky. The uniqueness of the Percunav system lies in its 3D ultrasound image fusion and navigation capabilities, which enable doctors to combine the advantages of different imaging techniques including CT, MR, PET, and ultrasound. This allows for more precise and accurate procedures, while reducing radiation exposure. However, the utilization of this technology requires understanding and overcoming the learning curve. Additionally, Dr. Ozen explores the various applications of this technology including biopsies, drain placements and other challenging interventions. --- SHOW NOTES 00:00 - Introduction 02:42 - Clinical Applications of 3D Fusion and Navigation Systems 11:43 - Limitations and Challenges of the Technology 17:30 - Exploring Different Needle Tracking Technologies 18:44 - Future Applications of the Technology 20:17 - Advice for Incorporating the Technology into Practice --- RESOURCES Percunav System: https://www.usa.philips.com/healthcare/product/HCNOCTN150/fusion-and-navigation-image-fusion-and-needle-navigation

Kristen is a Certified Internal Family Systems (IFS) Practitioner with the IFS Institute, with nearly 400 hours of IFS training in Levels 1, 2, and 3 and IFS couples and relational work (known as “Intimacy from the Inside Out” or "IFIO").  She has served as a Program Assistant for IFS Institute Level 1 and Level 2 trainings, is on staff for IFIO trainings, and has received a Certificate in Clinical Applications of IFS Therapy from the Adler Graduate Professional School.  Kristen also incorporates somatic and group work in her practice and has participated in an IFS Healing Circles workshop, Somatic IFS retreats, and is currently training in Somatic Experiencing.    Additionally, Kristen is licensed to practice as an attorney and certified mediator with Arrow Creek Law & Mediation, providing services in the areas of Indian tribal government law, tribal employment law, mediation, and alternative dispute resolution.  Kristen is passionate about the profound healing that is possible with the IFS model for individuals as well as groups and communities, and she appreciates its respectful and collaborative approach, including integration of legacy and cultural aspects, which are particularly important in working with indigenous communities.  She is inspired by the tremendous potential of IFS and IFIO for mediation, conflict resolution, and relationship building in light of the deepening polarizations witnessed throughout our society, and she remains hopeful in working towards a shift from an adversarial paradigm to one of collaboration and respect for all peoples.    kristen.burge@arrowcreekwellness.com pcsintensive.com

In today's episode, we delve into the exciting realm of Artificial Intelligence (AI) in anesthesiology, uncovering its potential to revolutionize hospital systems and patient safety.We'll address common concerns about AI taking over jobs and emphasize why the human touch remains irreplaceable in healthcare.Segment 1: The Human ConnectionAI's role in healthcare isn't about replacing physicians; it's about augmenting their abilities.Patients seek a unique connection with their physicians that AI can't replicate.AI can reduce administrative tasks and enhance our focus on patients, such as minimizing Electronic Health Record (EHR) documentation.Segment 2: AI in Anesthesiology - A Scoping ReviewWe draw insights from two key papers:1.  Daniel A. Hashimoto, Elan Witkowski, Lei Gao, Ozanan Meireles, Guy Rosman; Artificial Intelligence in Anesthesiology: Current Techniques, Clinical Applications, and Limitations. Anesthesiology 2020; 132:379–394 2.  Bellini V, Valente M, Gaddi AV, Pelosi P, Bignami E. Artificial intelligence and telemedicine in anesthesia: potential and problems. Minerva Anestesiol. 2022 Sep;88(9):729-734. doi: 10.23736/S0375-9393.21.16241-8. Epub 2022 Feb 14. PMID: 35164492.Segment 3: 6 Key Themes of AI in the Operating Room (OR)PreoperativelyEvent Prediction: AI can classify ASA status, predict difficult airways, and recommend optimal anesthesia methods, enhancing safety.Intraop2. Depth of Anesthesia Assessment: AI, alongside BIS (Bispectral Index Monitoring), assesses the depth of anesthesia.AI's accuracy surpasses BIS in assessing depth, reducing the risk of intraoperative awareness3.  Control of Anesthesia Delivery: AI automates the delivery of paralytics and predicts drug pharmacokinetics for precise titration.4.  Ultrasound Guidance: AI assists in identifying critical structures during ultrasound, such as arteries and ideal vertebral levels for epidural placement.5.  Pain Management: AI analyzes whole-brain MRI to understand patients' responses to pain stimuli, improving our understanding of pain perception.6.  OR Logistics: AI attempts to optimize OR scheduling, staffing, and team dynamics but faces challenges due to the complexity of the OR environment                       Real-world data is essential for improving AI's accuracy in this domain.ConclusionWhile AI holds immense promise in anesthesiology, we must ensure it is fed with diverse and representative data to avoid perpetuating healthcare disparities.Pain is a personal experience, and AI must complement, not replace, our understanding of patients' pain.AI is a tool that can enhance efficiency and patient safety, but it will always work alongside the human touch in healthcare.Remember the words of Rodney Brooks, an Australian roboticist and entrepreneur: "Artificial intelligence is a tool, not a threat." AI's potential lies in its ability to support healthcare professionals and ultimately improve patient outcomesWant to keep the convo going? Join our FB group!https://www.facebook.com/groups/sevosistasHave a burning question? A concern? A controversy or issue you want to hear covered? We got you, boo! Leave a voice message at 202 743 1404. We will play your recording on the podcast and address your topic (if you don't want it played just say it in the voicemail, we will still cover your topic!). This podcast is for you and we want to include you on this journey! Hope to hear from you soon

E314– Inner Voice – A Heartfelt Chat with Dr. Foojan. In this episode, Dr. Foojan Zeine chats with Dr. Stephen W. Porges, a Distinguished University Scientist at Indiana University, where he is the founding director of the Traumatic Stress Research Consortium. He is a Professor of Psychiatry at the University of North Carolina and a Professor Emeritus at the University of Illinois at Chicago and the University of Maryland. He was president of the Society for Psychophysiological Research and the Federation of Associations in Behavioral & Brain Sciences. He was a former recipient of a National Institute of Mental Health Research Scientist Development Award. He has published over 400 peer-reviewed papers across several disciplines, including anesthesiology, biomedical engineering, critical care medicine, ergonomics, exercise physiology, gerontology, neurology, neuroscience, obstetrics, pediatrics, psychiatry, psychology, psychometrics, space medicine, and substance abuse. In 1994, he proposed the Polyvagal Theory, which links the evolution of the mammalian autonomic nervous system to social behavior and emphasizes the importance of the physiological state in expressing behavioral problems and psychiatric disorders. The theory leads to innovative treatments based on insights into the mechanisms mediating symptoms observed in several behavioral, psychiatric, and physical disorders. He is the author of The Polyvagal Theory: Neurophysiological foundations of Emotions, Attachment, Communication, and Self-regulation (Norton, 2011), The Pocket Guide to the Polyvagal Theory: The Transformative Power of Feeling Safe (Norton, 2017), co-editor of Clinical Applications of the Polyvagal Theory: The Emergence of Polyvagal-Informed Therapies (Norton, 2018) and author of Polyvagal Safety: Attachment, Communication, Self-Regulation (Norton 2021). Dr. Porges is the creator of a music-based intervention, the Safe and Sound Protocol ™ (SSP), used by therapists to improve social engagement, language processing, and state regulation and reduce hearing sensitivities. https://www.stephenporges.com/ Check out my website: www.FoojanZeine.com.